Hanmi Pharm to Dispose Treasury Shares for Incentives
한미사이언스
008930
Signal Score
Historical Avg Return (5d)
+0.03%
Data Coverage
60%n=180
Risk-adjusted indicator based on 180 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Disposal of 10,402 common shares
- • Disposal price: 390,500 KRW per share
- • Total disposal amount: 4,061,981,000 KRW
- • Disposal period: July 29, 2026 - August 28, 2026
- • Dilution effect: 0.08% of total outstanding shares
AI Analysis Summary
Hanmi Pharm, a subsidiary of Hanmi Science, decided to dispose of 10,402 common treasury shares at 390,500 KRW per share, totaling 4.06 billion KRW. The disposal, occurring between July 29 and August 28, 2026, is for employee productivity incentives (RSA) and performance incentives (RSU) for 662 employees. The dilution effect is minimal at 0.08% of total outstanding shares, suggesting a neutral to slightly positive impact as it aligns employee incentives with company performance.
How This Event Is Evaluated
Treasury Share Disposal Evaluation
Treasury share disposal events are evaluated by assessing supply impact, disposal method, and stated purpose.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Disposal size relative to shares outstanding
- Disposal method and timing
- Stated purpose (funding, compensation, etc.)
- Dilution / supply impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.